Fundamentals of big data and artificial intelligence in transfusion medicine
Year: 2026
Type: article
Abstract: Within the digital transformation of medicine, transfusion medicine has quietly become a big-data discipline. The long-standing tradition of blood product standardization (e.g., ISBT-128) and large donor cohorts being followed over years-some of which are sampled in national biobank projects, build a favourable setting. In parallel, recent advances in artificial intelligence (AI) and data integration facilitate efficient data use for research and clinical care. Consequently, next-generation blood services might monitor donor phenotype data and match this information to AI-predicted recipient demands and their outcomes. Here, we attempt to provide a comprehensive introduction to the possibilities and challenges of big data and AI in transfusion medicine along with data integration opportunities related to the Fast Healthcare Interoperability Resources standard. We educate on the principles of AI and the digital transformation of transfusion medicine and analyse the evidence of blood establishments as digital platforms. We illustrate possible roadmaps for data integration and how federated learning initiatives and national networks may scale value while preserving donor and patient privacy. Finally, we exemplify the ongoing transformation with precision red blood cell (RBC) diagnostics using lab-on-a-chip and the digital crossmatch. The practice of transfusion medicine is undergoing transformation and experimentally appears to profit from synergies in precision diagnostics and AI. Its translation into routine practice remains a challenge for the current decade to leverage the full potential of blood establishments as 'big-data engines'.
Source: Vox Sanguinis
DOI: 10.1111/vox.70227
Authors: Amin T. Turki, Christian Martin Brieske, Umut A. Gurkan, Katja M. Scheidler, O. Berk Usta, Esa Turkulainen, Kamyar Arzideh, Christian Temme, René Hosch, Peter A. Horn, Mikko Arvas
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $4,150
Awards: RHODA: Rapid Hemoglobin-Oxygen Dissociation Assay, Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability, Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing, Deep Supercooling of Red Blood Cells: Towards Practical Long Term Storage, Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health), Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias, A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease
OpenAlex ID: W7140139709
